Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KAD-1229 (mitiglinide) plus pioglitazone in type 2 diabetes mellitus
jRCT2080220136Phase 3
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of mitiglinide in type 2 diabetes mellitus (T2DM), sponsored by Kissei Pharmaceutical Co., Ltd.
02
Drugs
mitiglinide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220136.